Inari Medical Receives Buy Recommendation with Adjusted Price Target
On February 29, 2024, Canaccord Genuity analyst William Plovanic reiterated his Buy recommendation on Inari Medical (NASDAQ:NARI) while adjusting the ...
Tag: NARI
Analyst Ratings and Price Targets for Inari Medical NASDAQNARI
As we enter the year 2024, analysts have been actively sharing their assessments of Inari Medical (NASDAQ:NARI), offering a wide ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
